Hand And Wrist Implants Market Global Report 2026

The hand and wrist implants market size has grown strongly in recent years. It will grow from $1.78 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period was driven by the increasing prevalence of hand and wrist injuries due to accidents and trauma, the rising incidence of osteoarthritis and rheumatoid arthritis, growing adoption of orthopedic surgical procedures, increasing demand for improved mobility and pain management solutions, and rising healthcare infrastructure development across emerging economies.

The hand and wrist implants market size is expected to see strong growth in the next few years. It will grow to $2.64 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to the increasing adoption of 3D-printed implant technologies, growing demand for personalized orthopedic implants, rising investments in advanced orthopedic research and development, an increasing geriatric population requiring joint replacement procedures, and expanding availability of specialized hand and wrist surgical treatments. Major trends in the forecast period include the increasing adoption of patient-specific hand and wrist implants, growing demand for minimally invasive implantation procedures, rising use of advanced biomaterials in implant manufacturing, increasing focus on improving functional recovery after implantation, and growing development of customized joint reconstruction solutions.

The increasing prevalence of osteoarthritis is expected to propel the growth of the hand and wrist implants market going forward. Osteoarthritis is a degenerative joint disease in which the protective cartilage between bones gradually wears away, causing pain, stiffness, and reduced joint mobility. The prevalence of osteoarthritis is increasing due to rising obesity rates, as excess body weight places greater mechanical stress on weight-bearing joints such as the knees and hips, accelerating cartilage deterioration and joint damage. Hand and wrist implants improve joint function and relieve pain in patients with osteoarthritis by replacing or stabilizing damaged bones and joints, helping restore hand mobility and support daily activities. For instance, in February 2025, according to Springer Nature, a UK-based academic and professional publishing company, the number of knee osteoarthritis cases was estimated at 12.94 million among males and 18.80 million among females in 2022, with projections rising to 18.45 million among males and 25.60 million among females by 2046. Therefore, the increasing prevalence of osteoarthritis is driving the growth of the hand and wrist implants market.

Major companies operating in the hand and wrist implants market are focusing on developing innovative products, such as variable-angle wrist arthrodesis plating systems, to improve surgical precision, strengthen fixation stability, and enable customized treatment for complex wrist reconstruction procedures. Variable-angle wrist arthrodesis plating systems are orthopedic implant solutions featuring adjustable screw angulation technology that allows surgeons to customize screw placement according to patient anatomy and surgical requirements, improving fixation flexibility, optimizing bone alignment, and enhancing post-operative stability compared to conventional fixed-angle plating systems. For instance, in April 2026, GMReis USA Corp., a US-based orthopedic device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its wrist arthrodesis comprehensive plating system. The system incorporates variable-angle plate technology designed to address a wide range of wrist arthrodesis procedures, from total to partial wrist fusion anatomies, allowing surgeons to tailor treatment to individual patient conditions. It also includes low-profile anatomical plate designs, flexible fixation configurations, and solutions supporting multiple surgical approaches to improve procedural adaptability and patient outcomes.

In April 2024, Henry Schein Inc., a US-based healthcare products and services company, acquired TriMed Inc. for an undisclosed amount. Through this acquisition, Henry Schein aims to strengthen its position in the extremities orthopedics segment by expanding its portfolio of upper-extremity solutions, including hand and wrist implants, fixation systems, and trauma devices. TriMed Inc. is a US-based company that specializes in upper extremity orthopedics and provides a comprehensive suite of hand and wrist implants.

Major companies operating in the hand and wrist implants market are Acumed LLC, Arthrex Inc., Enovis Corporation, Extremity Medical LLC, Integra LifeSciences Holdings Corporation, ITS Implants Technologies GmbH, Jeil Medical Corporation, Johnson & Johnson, KLS Martin Group, Königsee Implantate GmbH, Medartis Holding AG, Newclip Technics SAS, Orthofix Medical Inc., Osteomed LLC, Paragon 28 Inc., Skeletal Dynamics LLC, Smith & Nephew plc, Stryker Corporation, Trimed Inc., Zimmer Biomet Holdings Inc.

North America was the dominating region in the hand and wrist implants market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the hand and wrist implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hand and wrist implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.